12:00 AM
 | 
Jun 15, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Kapidex dexlansoprazole gastrointestinal data

Data from a prospective study of 63,878 hospital admissions showed that patients receiving acid-suppressive medication (n=32,922), which included proton pump inhibitors (PPIs) or histamine H2 receptor antagonists, had a 30% increased risk of HAP vs. patients not receiving acid-suppressive medication (n=30,956). The association was significant for PPIs (n=25,374), but not...

Read the full 237 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >